Skip to content

Clinical trials

Completed Breast Neoplasms trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Saudi Arabia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20061
20081
20091
20101
20111
20122
20142
20163
20172
20181
20191
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Novartis Pharmaceuticals3
King Faisal Specialist Hospital & Research Center2
Pfizer2
AstraZeneca1
Eastern Cooperative Oncology Group1
Eli Lilly and Company1
International Cancer Research Group, United Arab Emirates1
King Abdulaziz University1
King Fahad Medical City1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms24
Neoplasm Metastasis3
Breast Neoplasms, Male1
Carcinoma, Non-Small-Cell Lung1
Lung Neoplasms1
Lymphatic Metastasis1
Multiple Myeloma1
Neoplasms1
Neoplasms, Plasma Cell1
Prostatic Neoplasms1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.